Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve.
Visco V, Izzo C, Mancusi C, Rispoli A, Tedeschi M, Virtuoso N, Giano A, Gioia R, Melfi A, Serio B, Rusciano MR, Di Pietro P, Bramanti A, Galasso G, D'Angelo G, Carrizzo A, Vecchione C, Ciccarelli M. Visco V, et al. Among authors: serio b. J Cardiovasc Dev Dis. 2023 Feb 9;10(2):74. doi: 10.3390/jcdd10020074. J Cardiovasc Dev Dis. 2023. PMID: 36826570 Free PMC article. Review.
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA.
Risitano AM, Selleri C, Serio B, Torelli GF, Kulagin A, Maury S, Halter J, Gupta V, Bacigalupo A, Sociè G, Tichelli A, Schrezenmeier H, Marsh J, Passweg J, Rotoli B; Working Party Severe Aplastic Anaemia (WPSAA) of the European Group for Blood and Marrow Transplantation (EBMT). Risitano AM, et al. Among authors: serio b. Br J Haematol. 2010 Mar;148(5):791-6. doi: 10.1111/j.1365-2141.2009.08027.x. Epub 2009 Dec 7. Br J Haematol. 2010. PMID: 19995389 Free article. Clinical Trial.
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study.
Giudice V, Pagliano P, Vatrella A, Masullo A, Poto S, Polverino BM, Gammaldi R, Maglio A, Sellitto C, Vitale C, Serio B, Cuffa B, Borrelli A, Vecchione C, Filippelli A, Selleri C. Giudice V, et al. Among authors: serio b. Front Pharmacol. 2020 Jun 5;11:857. doi: 10.3389/fphar.2020.00857. eCollection 2020. Front Pharmacol. 2020. PMID: 32581810 Free PMC article.
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency.
Carrizzo A, Iside C, Nebbioso A, Carafa V, Damato A, Sciarretta S, Frati G, Di Nonno F, Valenti V, Ciccarelli M, Venturini E, Scioli M, Di Pietro P, Bucci T, Giudice V, Storto M, Serio B, Puca AA, Giugliano G, Trimarco V, Izzo R, Trimarco B, Selleri C, Altucci L, Vecchione C. Carrizzo A, et al. Among authors: serio b. Cell Mol Life Sci. 2022 Jul 11;79(8):410. doi: 10.1007/s00018-022-04429-5. Cell Mol Life Sci. 2022. PMID: 35821533 Free PMC article.
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience.
Giudice V, Serio B, Ferrara I, Manzo P, Gorrese M, Pepe R, Bertolini A, D'Alto F, Verdesca F, Langella M, Filippelli A, Selleri C. Giudice V, et al. Among authors: serio b. Front Pharmacol. 2022 Dec 21;13:1052060. doi: 10.3389/fphar.2022.1052060. eCollection 2022. Front Pharmacol. 2022. PMID: 36618908 Free PMC article.
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Giudice V, Gorrese M, Vitolo R, Bertolini A, Marcucci R, Serio B, Guariglia R, Ferrara I, Pepe R, D'Alto F, Izzo B, Pedicini A, Montuori N, Langella M, Selleri C. Giudice V, et al. Among authors: serio b. Biomedicines. 2021 Apr 6;9(4):387. doi: 10.3390/biomedicines9040387. Biomedicines. 2021. PMID: 33917307 Free PMC article.
86 results